Comments
Loading...
Heron Therapeutics (HRTX) Forecast
NewsEarningsHeron Therapeutics (HRTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHeron Therapeutics (NASDAQ:HRTX) Stock Quotes, Forecast and News Summary
Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Heron Therapeutics (HRTX) stock?
You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.
Who are Heron Therapeutics (HRTX) competitors?
Other companies in Heron Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Monopar Therapeutics (NASDAQ:MNPR), Tango Therapeutics (NASDAQ:TNGX) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the forecast, or price target, for Heron Therapeutics (HRTX) stock?
Heron Therapeutics has a consensus price target of $6.75.
What is the current price for Heron Therapeutics (HRTX)?
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $1.745 last updated February 21, 2025 at 10:45 AM EST.
Does Heron Therapeutics (HRTX) pay a dividend?
There are no upcoming dividends for Heron Therapeutics.
When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?
Heron Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Heron Therapeutics (HRTX) going to split?
There is no upcoming split for Heron Therapeutics.
What sector and industry does Heron Therapeutics (HRTX) operate in?
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.